Skip to search formSkip to main contentSkip to account menu

TT2-32

Known as: TT 232, TT-232 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Somatostatin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.
BACKGROUND The somatostatin structural deivative, TT-232, has a special 5'-residue ring structure (D-Phe-Cys-Tyr-D-Trp-Lys-Cys… 
2006
2006
Evaluation of the antitumor efficacy of the somatostatin structural derivative TT-232 on different tumor models.
The antitumor effects of the somatostatin structural derivative TT-232 in different rodent and xenograft tumor models are… 
2006
2006
A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.
The tumor growth inhibitory efficacy of the somatostatin structural derivative TT-232 was studied using different routes of… 
2005
2005
Growth inhibitory effect of the somatostatin structural derivative (TT-232) on leukemia models.
TT-232 is a structural derivative of the natural signal inhibitory peptide somatostatin, with selective antiproliferative and… 
2003
2003
The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.
A somatostatin structural derivative (TT-232) has been developed in our laboratory with strong antiproliferative effect but no GH… 
2001
2001
The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCdelta and c-Src.
The heptapeptide TT-232 is structurally related to the hypothalamic hormone somatostatin and shows promise as an anticancer drug… 
2001
2001
Antiproliferative efficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours.
BACKGROUND TT-232, a somatostatin analogue, induces apoptosis in various tumours. The aim of our study was to characterise its… 
2000
2000
Influence of various administration routes on the antitumor efficacy ofTT-232, a novel somatostatin analog.
TT-232 a novel tumor-selective somatostatin analog with a five residue ring structure (D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-NH2) was… 
Review
2000
Review
2000
Peptides and antitumor activity
We developed a group of synthetic analogs of GnRH and Somatostatin to inhibit the tumor growth of different kind. The GnRH… 
1993
1993
Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
A series of new somatostatin analogs were synthesized in order to study the relative importance of specific substitutions in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)